AI assistant
Sending…
Zymeworks Inc. — Director's Dealing 2026
Jan 13, 2026
32180_dirs_2026-01-13_6b897514-415d-48b7-a7ec-797708b5ff95.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Zymeworks Inc. (ZYME)
CIK: 0001937653
Period of Report: 2026-01-12
Reporting Person: Cherry Brian N (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-01-12 | Stock Option (Right to Buy) | $23.16 | A | 23000 | Acquired | 2036-01-11 | Common Stock (23000) | Direct |
| 2026-01-12 | Restricted Stock Unit | $ | A | 15400 | Acquired | Common Stock (15400) | Direct |
Footnotes
F1: Stock options vest in 36 equal monthly installments starting one month after grant date of January 12, 2026.
F2: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of common stock.
F3: RSUs vest in three equal annual installments beginning on first anniversary of grant date.